[L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].
D006916:5-Hydroxytryptophan / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001565:Benzoates / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D012701:Serotonin / Q000096:biosynthesis; D014282:Trihexyphenidyl / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D001565:Benzoates; D012701:Serotonin; D014282:Trihexyphenidyl; D006916:5-Hydroxytryptophan
L-5-Hydroxytryptophan(L-5-HTP)-Therapie bei endogener Depression. 1.